Atlas Trials

A Study of LY2216684 in Major Depressive Disorder in Patients Taking Selective Serotonin Reuptake Inhibitors

Clinical trial NCT01263223 · COMPLETED

Trial details

NCT number
NCT01263223
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2010-12-01
Primary completion
2011-03-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.